News
STXS
1.420
-1.39%
-0.020
Stereotaxis Q2 Widens On Lower Revenue, Higher Expenses; Provides Outlook
NASDAQ · 6d ago
Weekly Report: what happened at STXS last week (0810-0814)?
Weekly Report · 6d ago
Stereotaxis price target lowered to $3 from $4 at Lake Street
TipRanks · 6d ago
Stereotaxis Earnings Call Signals Early Growth Inflection
TipRanks · 08/13 00:07
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
NASDAQ · 08/12 18:33
Stereotaxis Price Target Cut to $3.00/Share From $5.00 by TD Cowen
Dow Jones · 08/12 15:32
Stereotaxis Is Maintained at Buy by TD Cowen
Dow Jones · 08/12 15:32
TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3
Benzinga · 08/12 15:22
Lake Street Reaffirms Their Buy Rating on Stereotaxis (STXS)
TipRanks · 08/12 13:36
Here are the major earnings before the open Wednesday
Seeking Alpha · 08/11 22:00
Stereotaxis reports Q2 EPS (5c), consensus (5c)
TipRanks · 08/11 20:05
*Stereotaxis System Rev Is Expected to Be Approximately $3 M in Each of the Third and Fourth Quarters >STXS
Dow Jones · 08/11 20:02
*Stereotaxis Believes Can Advance Strategy, Integrate Robocath, and Grow Rev Without Subjecting Investors to Substantial Dilution >STXS
Dow Jones · 08/11 20:02
*Stereotaxis 2Q Loss/Shr 5c >STXS
Dow Jones · 08/11 20:01
Press Release: Stereotaxis Reports 2026 Second -2-
Dow Jones · 08/11 20:01
Press Release: Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
Dow Jones · 08/11 20:01
*Stereotaxis Anticipates Recurring Rev to Grow to Approximately $7 M in the 3Q and $8 M in the 4Q >STXS
Dow Jones · 08/11 20:01
*Stereotaxis 2Q Rev $7.67M >STXS
Dow Jones · 08/11 20:01
Here are the major earnings after the close Tuesday
Seeking Alpha · 08/11 14:00
Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Stereotaxis (STXS) and Tvardi Therapeutics (TVRD)
TipRanks · 08/11 06:30
More
Webull provides a variety of real-time STXS stock news. You can receive the latest news about Stereotaxis Ord through multiple platforms. This information may help you make smarter investment decisions.
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.